Benitec Biopharma (BNTC) Interest Coverage Ratio (QoQ) (2020 - 2025)
Benitec Biopharma (BNTC) Interest Coverage Ratio (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -159,792.44% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | -2,190,400.15% |
| Mar 31, 2025 | -21.46% |
| Dec 31, 2024 | 12.90% |
| Sep 30, 2024 | 49.67% |
| Jun 30, 2024 | 79.80% |
| Mar 31, 2024 | 98.09% |
| Dec 31, 2023 | 96.43% |
| Sep 30, 2023 | -4,387.51% |
| Jun 30, 2023 | 86.77% |
| Mar 31, 2023 | 62.52% |
| Dec 31, 2022 | -34.79% |
| Sep 30, 2022 | -2,070.74% |
| Jun 30, 2022 | 98.93% |
| Mar 31, 2022 | 22.30% |
| Dec 31, 2021 | -50.40% |
| Sep 30, 2021 | -5.33% |
| Jun 30, 2021 | 95.77% |
| Mar 31, 2021 | -4,599.06% |